Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-09-014495

Chief Financial Officer acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CULPEPPER PETER R · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2009-06-11 Exercise or conversion : show line 1 in the form +150,000 $0.64 $96,000 410,376 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2009-06-11 Exercise or conversion : show line 2 in the form Stock Options (Right to buy) −150,000 $0.64 2015-01-07 150,000 0 D
Loading xslF345X03/doc1.xml…